New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]

About this Item

Title: New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]
Author: Merck & Co.
Canvas: Page 1 - Title Page
Publication: Merck; 1997-01-26
: Chronological Files > 1997 > Events > Conference on Retroviruses and Opportunistic Infections (4th : 1997 : Washington, D.C.)
Item type:: press releases

Collection: Jon Cohen AIDS Research Collection
Link to this Item: https://name.umdl.umich.edu/5571095.0120.055
Link to this scan: https://quod.lib.umich.edu/c/cohenaids/5571095.0120.055/1

Where applicable, subject to copyright. Other restrictions on distribution may apply. Please go to http://www.umdl.umich.edu/ for more information.

Manifest: https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0120.055

Full citation: "New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0120.055. University of Michigan Library Digital Collections. Accessed May 9, 2024.